Evidence map›Paper›PMID 41684579›Full record

ArticleArchives of medical science : AMS2025

Therapeutic effect of

Xuran Li, Meng Xing, Yinzhu Zhang, Ming Yang

Abstract read
In one paragraph

Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xuran LiDepartment of Pediatrics, Beijing United Family Hospital, Beijing, China.
Meng XingDepartment of Pediatrics, Beijing United Family Hospital, Beijing, China.
Yinzhu ZhangDepartment of Pediatrics, Beijing United Family Hospital, Beijing, China.
Ming YangDepartment of Pediatrics, Beijing United Family Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Preterm infants have an immature gastrointestinal tract with incomplete establishment of intestinal flora; therefore, they are highly prone to feeding intolerance. The objective of the study was to observe the therapeutic effect of specific probiotics ( Material and methods: Fifty-six preterm infants delivered between January 2016 and May 2022 were enrolled in this retrospective study. We analysed the clinical data of these children and followed up their treatment outcomes by telephone for 3 to 6 months after discharge. The treatment schemes were scheme A ( Results: Among the 56 children were 31 males and 25 females. In scheme B, the duration of switching from intravenous nutrition to full enteral feeding at a gestational age of > 28 weeks and a birth weight of ≤ 1,500 g was significantly different from that in scheme A ( Conclusions:

Indexed as

intolerance of feedingLactobacillus reuteri DSM 17938premature infants

Identifiers

PMID41684579
PMCPMC12892264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.